[Form 4] AmeriServ Financial Inc Insider Trading Activity

Rhea-AI Filing Summary

Daniel A. Onorato, a director of AmeriServ Financial, reported acquiring 549 shares of AmeriServ Financial Inc. (ASRV) on 08/18/2025 through dividend reinvestment at an effective per-share price of $3.0109. After the transaction the reporting person beneficially owned 56,701 shares, held directly. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 08/27/2025. The filing discloses a routine, non-derivative purchase tied to dividend reinvestment rather than an open-market trade or stock grant.

Positive

• Ownership increased by 549 shares through dividend reinvestment, raising beneficial ownership to 56,701 shares
• Filing compliance: Form 4 was completed and signed by an attorney-in-fact, indicating procedural adherence

Negative

• None.

Insights

Securities Analyst

TL;DR: Small, routine ownership increase via dividend reinvestment; limited market impact.

The Form 4 shows a non-derivative acquisition of 549 shares at $3.0109 per share through a dividend reinvestment plan, bringing the holder to 56,701 shares. This is an administratively driven increase rather than a discretionary purchase and does not indicate a change in compensation or a large-scale insider buying program. For investors, the filing documents insider ownership continuity but is unlikely to move valuation or signal material new information.

Corporate Governance Expert

TL;DR: Compliance filing documents routine dividend reinvestment; governance impact is minimal.

The disclosure identifies the reporting person as a director and reports shares acquired via dividend reinvestment, a common mechanism that maintains or modestly increases insider ownership without active trading. The Form 4 was timely and signed via attorney-in-fact, meeting procedural requirements. There are no derivative transactions, no changes in officer status, and no indications of material corporate actions in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Onorato Daniel A.

(Last) (First) (Middle)

216 FRANKLIN STREET

(Street)

JOHNSTOWN PA 15901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMERISERV FINANCIAL INC /PA/ [ ASRV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		A		549(1)	A	$3.0109	56,701	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired through dividend reinvestment.

	Sharon M. Callihan - Attorney-in-Fact	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Daniel A. Onorato report on Form 4 for ASRV?

He reported acquiring 549 shares of AmeriServ Financial Inc. (ASRV) via dividend reinvestment on 08/18/2025.

At what price were the ASRV shares acquired according to the Form 4?

The reported price per share was $3.0109 for the 549 shares acquired.

How many ASRV shares does the reporting person own after the transaction?

56,701 shares beneficially owned following the reported transaction.

Was the transaction a market purchase, option exercise, or dividend reinvestment?

The transaction was a dividend reinvestment, as explicitly stated in the filing explanation.

When was the Form 4 signed and filed?

The form shows an attorney-in-fact signature dated 08/27/2025 and the transaction date of 08/18/2025.